Press Release : Cyrano Therapeutics Announces the Launch of an Investigator-Initiated Clinical Study Evaluating CYR-064 for the Loss of Smell (Hyposmia) in Parkinson’s Disease Patients
DELRAY BEACH, Fla., Feb. 4, 2025 /PRNewswire/ — Cyrano Therapuetics,inc., a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, announced today that it is providing clinical material to support an investigator-led feasibility study evaluating CYR-064 in Parkinson’s Disease patients….